Clinical trial
The Formation and Severity of Pressure Ulcers Associated With 4% Albumin vs. 0.9% Sodium Chloride Administration (Substudy of SAFE Protocol 153711)
NCT00228657 is registered in ClinicalTrials.gov with Bayside Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Formation and Severity of Pressure Ulcers Associated With 4% Albumin vs. 0.9% Sodium Chloride Administration (Substudy of SAFE Protocol 153711)
- Lead sponsor
- Bayside Health
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- July 31, 2002
- Completion date
- August 31, 2003
- Enrollment
- 1,100
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
albumin level, length of icu stay, pressure ulcer, area, pressure ulcer, grade, risk score